Lang Li
Papers
1
Total Citations
6
H-Index
1
About
Lang Li is a pioneering researcher in precision nanomedicine and thrombolytic therapy, whose work addresses critical challenges in stroke treatment. His most notable contribution is the development of an artificial biomarker-based feedback-regulated system for personalized thrombolysis, detailed in his highly cited 2025 paper (6 citations). This groundbreaking approach tackles the fundamental defects of body weight-based thrombolytic strategies—namely, low recanalization rates and high hemorrhagic risk—by enabling real-time perception of thrombus heterogeneity and thrombolysis resistance. Li’s research uniquely integrates biomaterials engineering with clinical pharmacology, creating a feedback loop that dynamically adjusts drug delivery to individual patient needs. His work has profound implications for reducing post-thrombolysis hemorrhage, a major cause of disability and death. By shifting from one-size-fits-all dosing to precise, adaptive therapy, Li is redefining standards in vascular intervention. His innovative methodology, combining artificial biomarkers with closed-loop regulation, positions him at the forefront of personalized medicine, offering safer, more effective solutions for acute ischemic stroke and other thrombotic disorders.
Research Focus
Key Achievements
Top Papers
- 1